[HTML][HTML] Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance

J Cooper, FG Giancotti - Cancer cell, 2019 - cell.com
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …

Vessel co-option in cancer

EA Kuczynski, PB Vermeulen, F Pezzella… - Nature reviews Clinical …, 2019 - nature.com
All solid tumours require a vascular supply in order to progress. Although the ability to
induce angiogenesis (new blood vessel growth) has long been regarded as essential to this …

Resistance mechanisms to anti-angiogenic therapies in cancer

Y Haibe, M Kreidieh, H El Hajj, I Khalifeh… - Frontiers in …, 2020 - frontiersin.org
Tumor growth and metastasis rely on tumor vascular network for the adequate supply of
oxygen and nutrients. Tumor angiogenesis relies on a highly complex program of growth …

Resistance to anti-angiogenic therapy in cancer—alterations to anti-VEGF pathway

Y Itatani, K Kawada, T Yamamoto, Y Sakai - International journal of …, 2018 - mdpi.com
Anti-angiogenic therapy is one of the promising strategies for many types of solid cancers.
Bevacizumab (Avastin), a recombinant humanized monoclonal antibody of vascular …

[HTML][HTML] Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery

J Schnittert, R Bansal, G Storm, J Prakash - Advanced drug delivery reviews, 2018 - Elsevier
Wound healing is a complex process, which ultimately leads to fibrosis if not repaired well.
Pathologically very similar to fibrosis is the tumor stroma, found in several solid tumors which …

Dissecting and rebuilding the glioblastoma microenvironment with engineered materials

KJ Wolf, J Chen, JD Coombes, MK Aghi… - Nature Reviews …, 2019 - nature.com
Glioblastoma (GBM) is the most aggressive and common form of primary brain cancer.
Several decades of research have provided great insight into GBM progression; however …

[HTML][HTML] Fibronectin: how its aberrant expression in tumors may improve therapeutic targeting

JP Wang, A Hielscher - Journal of Cancer, 2017 - ncbi.nlm.nih.gov
Fibronectin is a matrix glycoprotein which has not only been found to be over-expressed in
several cancers, but has been shown to participate in several steps of tumorigenesis. The …

[HTML][HTML] Extracellular matrix-cell interactions: Focus on therapeutic applications

A Sainio, H Järveläinen - Cellular signalling, 2020 - Elsevier
Extracellular matrix (ECM) macromolecules together with a multitude of different molecules
residing in the extracellular space play a vital role in the regulation of cellular phenotype and …

Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion

HA Kenny, CY Chiang, EA White… - The Journal of …, 2014 - Am Soc Clin Investig
Ovarian cancer (OvCa) metastasizes to organs in the abdominal cavity, such as the
omentum, which are covered by a single layer of mesothelial cells. Mesothelial cells are …

Redox signaling in drug-tolerant persister cells as an emerging therapeutic target

Z Zhang, Y Tan, C Huang, X Wei - EBioMedicine, 2023 - thelancet.com
Drug-tolerant persister (DTP) cells have attracted significant interest, given their
predominant role in treatment failure. In this respect, DTP cells reportedly survive after …